Global Wealth Strategies & Associates Abb Vie Inc. Transaction History
Global Wealth Strategies & Associates
- $304 Billion
- Q3 2024
A detailed history of Global Wealth Strategies & Associates transactions in Abb Vie Inc. stock. As of the latest transaction made, Global Wealth Strategies & Associates holds 438 shares of ABBV stock, worth $88,257. This represents 0.03% of its overall portfolio holdings.
Number of Shares
438
Previous 418
4.78%
Holding current value
$88,257
Previous $71.7 Million
20.64%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
3,760Shares Held
1.28BCall Options Held
13MPut Options Held
9.83M-
Vanguard Group Inc Valley Forge, PA171MShares$34.4 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.8 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.78 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $356B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...